Behind the Scenes of Edwards Lifesciences's Latest Options Trends
Portfolio Pulse from Benzinga Insights
Recent options trading activity for Edwards Lifesciences (NYSE:EW) shows a predominantly bearish sentiment among investors, with 87% of detected trades being bearish. The trading volume highlights a targeted price range of $80.0 to $95.0 for EW over the last 3 months. Current trading volume and analyst ratings suggest mixed views on the stock's future, with a current price of $86.45 and an average analyst price target of $99.8. The company is a leader in medical devices for structural heart disease, with significant sales outside the US.
April 18, 2024 | 8:32 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Predominantly bearish options trading activity and mixed analyst ratings indicate uncertainty around Edwards Lifesciences's stock. The targeted price range from options trading is $80 to $95, with the stock currently at $86.45 and an average analyst target of $99.8.
The bearish sentiment in options trading, combined with the current stock price being within the targeted range but below analyst expectations, suggests a cautious outlook. However, the presence of both bullish and bearish trades, along with varied analyst ratings, introduces uncertainty, leading to a neutral short-term impact score.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 100